Dr. Benjamin C. Creelan, pleural mesothelioma doctor

Benjamin C. Creelan

Medical Oncologist

Dr. Benjamin Creelan is a medical oncologist at the H. Lee Moffitt Cancer Center in Tampa, Florida. He focuses on the translational and clinical research that leads to advancing treatment for lung cancer and pleural mesothelioma.

Get in touch

Content Contributors


Written By

Edited By

This page features: 11 cited research articles

About Benjamin C. Creelan

  • Board Certified icon

    Board Certified in Medical Oncology

  • Immunotherapy icon


  • Research Excellence icon

    Excellence in Research

  • Pleural and Lung Cancer icon

    Pleural Mesothelioma

  • Works for Specialty Center icon

    Works for Specialty Center

Creelan plays a key role in the Thoracic Oncology Program at Moffitt Cancer Center that has been lauded for its innovative approach, mixing cutting-edge discoveries with old-fashioned personalization of care.

“I think a patient’s best chance at beating their cancer is with the Moffitt Cancer Center,” he said confidently.

Creelan has focused on emerging immunotherapies that already are working for various thoracic malignancies.

He is involved in several clinical trials, allowing patients to benefit from the latest advances that are working their way through the Food and Drug Administration approval process.

“Lung cancer, for example, has had so many advancements in recent years. It’s become a much more complicated field,” he said. “Traditionally, we always treated lung cancer by targeting the cancer cells. Now we are targeting the patient’s own immune system. And every patient has an immune system that is capable of killing cancer cells.”

Leading Immunotherapy Research

Creelan is running a much-anticipated clinical trial with Opdivo (nivolumab) for patients with advanced or solid tumors.

Opdivo already has shown great success with several cancers, including lung cancer.

One of the studies aimed at mesothelioma patients involves the immunotherapy combination of Opdivo and Cyramza (ramucirumab), which has the potential to replace chemotherapy and avoid many of the complications that often accompany it.

“My goal is to use clinical trials to activate the immune system to fight the cancer,” he said.

He also is working on a phase II clinical trial testing transarterial chemoperfusion for unresectable pleural mesothelioma.

The procedure involves identifying specific blood vessels that feed mesothelioma tumors, then sending higher-than-normal doses of chemotherapy to slow or stop their growth.

Another clinical trial is studying a chemotherapy combination designed specifically for mesothelioma patients with low expression of the enzyme argininosuccinate synthetase 1.

Career Stops in Maryland, Pennsylvania and Florida

Creelan graduated from the Jefferson Medical College in Maryland.

He did his residency in internal medicine at Thomas Jefferson University in Philadelphia.

Creelan completed a hematology oncology fellowship at the University of South Florida before accepting a position at Moffitt.

He received a master’s degree in clinical and translational research through a sponsorship from the National Institutes of Health.

Disclaimer: Dr. Benjamin C. Creelan has no professional affiliation with Asbestos.com.

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer.

Get the Best Treatment Options

Find a Doctor
Asbestos.com Mesothelioma Packet

Order Your Free Treatment Guide

Get Yours Now

Find a Mesothelioma Clinical Trial Near You

Get Help Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Matt Mauney, Content Writer at Asbestos.com
Edited by

1 Cited Article Sources

  1. Moffitt Cancer Center. (n.d.). Benjamin C. Creelan, MD. Retrieved from: https://moffitt.org/providers/benjamin-creelan/

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

On This Page

Back to Top

Share this article

Last Modified April 8, 2019

Get Your Free Mesothelioma Guide Chat live with a patient advocate now